Total Payments
$126,544
2024 Payments
$835.29
Companies
55
Transactions
347
Medicare Patients
1,875
Medicare Billing
$208,184
Payment Breakdown by Category
Research$120,504 (95.2%)
Food & Beverage$5,994 (4.7%)
Education$46.82 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $120,504 | 4 | 95.2% |
| Food and Beverage | $5,994 | 336 | 4.7% |
| Education | $46.82 | 7 | 0.0% |
Payments by Type
Research
$120,504
4 transactions
General
$6,041
343 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $120,504 | 4 | $0 (2021) |
| Novo Nordisk Inc | $994.23 | 67 | $0 (2024) |
| Lilly USA, LLC | $686.57 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $480.04 | 13 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $342.68 | 14 | $0 (2021) |
| UPSHER-SMITH LABORATORIES LLC | $206.25 | 10 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $204.99 | 10 | $0 (2020) |
| PFIZER INC. | $204.56 | 16 | $0 (2024) |
| ABBVIE INC. | $180.61 | 18 | $0 (2022) |
| EISAI INC. | $164.83 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $835.29 | 33 | Lilly USA, LLC ($194.17) |
| 2023 | $358.53 | 17 | Novo Nordisk Inc ($62.59) |
| 2022 | $692.10 | 41 | Novo Nordisk Inc ($120.55) |
| 2021 | $965.50 | 61 | Eli Lilly and Company ($248.40) |
| 2020 | $121,273 | 68 | Eli Lilly and Company ($120,255) |
| 2019 | $479.67 | 35 | AstraZeneca Pharmaceuticals LP ($130.21) |
| 2018 | $1,016 | 47 | Janssen Pharmaceuticals, Inc ($268.73) |
| 2017 | $924.10 | 45 | Novo Nordisk Inc ($200.71) |
All Payment Transactions
347 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $68.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: UROLOGY | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: PAIN | ||||||
| 09/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Insomnia | ||||||
| 09/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.97 | General |
| Category: PSYCHIATRY | ||||||
| 09/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: RESPIRATORY | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Gastroenterology | ||||||
| 07/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: PSYCHIATRY | ||||||
| 07/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.90 | General |
| Category: Obesity | ||||||
| 07/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Oncology | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $6.65 | General |
| 06/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: UROLOGY | ||||||
| 06/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/21/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $6.65 | General |
| 05/17/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $6.65 | General |
| 05/01/2024 | ALK-Abello, Inc | Grastek (Drug), Odactra, Ragwitek | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Allergy and Immunology | ||||||
| 04/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.80 | General |
| Category: UROLOGY | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $89.78 | General |
| Category: Diabetes | ||||||
| 04/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.79 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: PAIN | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS | Eli Lilly and Company | $120,489 | 3 |
| PEDIATRIC OPTIONS FOR MIGRAINE RELIEF A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE PIONEER PEDS1 | Eli Lilly and Company | $14.38 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 488 | 1,130 | $149,557 | $56,983 |
| 2022 | 10 | 618 | 1,593 | $177,426 | $76,201 |
| 2021 | 7 | 363 | 625 | $60,170 | $38,751 |
| 2020 | 9 | 406 | 686 | $64,635 | $36,248 |
Total Patients
1,875
Total Services
4,034
Medicare Billing
$208,184
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 322 | $41,860 | $18,336 | 43.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $19,600 | $12,111 | 61.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 103 | $16,480 | $8,067 | 48.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 52 | 257 | $32,896 | $7,562 | 23.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 52 | 257 | $32,896 | $7,195 | 21.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $2,565 | $1,942 | 75.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 29 | $1,080 | $854.14 | 79.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $1,760 | $716.30 | 40.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 21 | $420.00 | $199.92 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 353 | $33,710 | $20,622 | 61.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 68 | 423 | $54,144 | $15,920 | 29.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 68 | 423 | $54,144 | $14,793 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $11,400 | $9,501 | 83.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 100 | $13,000 | $8,592 | 66.1% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 42 | 44 | $3,300 | $2,937 | 89.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 35 | 35 | $3,150 | $1,566 | 49.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 43 | $1,290 | $1,222 | 94.7% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 76 | 76 | $2,888 | $855.88 | 29.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 20 | $400.00 | $192.17 | 48.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 349 | $33,155 | $19,722 | 59.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $8,550 | $7,416 | 86.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 93 | $12,090 | $7,230 | 59.8% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 41 | 41 | $3,075 | $2,676 | 87.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 17 | 17 | $1,530 | $769.66 | 50.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 41 | 41 | $1,230 | $675.27 | 54.9% |
About Dr. Michael Winnie, MD
Dr. Michael Winnie, MD is a Family Medicine healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821196932.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Winnie, MD has received a total of $126,544 in payments from pharmaceutical and medical device companies, with $835.29 received in 2024. These payments were reported across 347 transactions from 55 companies. The most common payment nature is "" ($120,504).
As a Medicare-enrolled provider, Winnie has provided services to 1,875 Medicare beneficiaries, totaling 4,034 services with total Medicare billing of $208,184. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Corpus Christi, TX
- Active Since 09/20/2006
- Last Updated 08/17/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1821196932
Products in Payments
- Ozempic (Drug) $500.56
- FARXIGA (Drug) $413.34
- XARELTO (Drug) $324.99
- TRULICITY (Drug) $277.58
- REXULTI (Drug) $194.90
- Victoza (Drug) $182.29
- Dayvigo (Drug) $152.93
- Vascepa (Drug) $151.47
- XIFAXAN (Drug) $146.66
- ENTRESTO (Drug) $146.27
- TOSYMRA (Drug) $139.77
- MOUNJARO (Drug) $134.20
- ZENPEP (Drug) $125.40
- Wegovy (Drug) $121.90
- Tymlos (Biological) $121.34
- BELSOMRA (Drug) $111.15
- LONHALA MAGNAIR (Drug) $102.87
- JARDIANCE (Drug) $95.08
- VRAYLAR (Drug) $93.88
- Cologuard Collection Kit (Device) $83.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Corpus Christi
Belinda Gonzalez, Md, MD
Family Medicine — Payments: $19,036
Family Medicine $19,036
Ruben Almanza, Md, MD
Family Medicine — Payments: $17,359
Family Medicine $17,359
Robert Bolster, M.d, M.D
Family Medicine — Payments: $13,334
Family Medicine $13,334
Dr. Andres Nisimblat, M.d, M.D
Family Medicine — Payments: $11,410
Family Medicine $11,410
Dr. Erik Garza, M.d, M.D
Family Medicine — Payments: $9,683
Family Medicine $9,683
Dr. Frank Martinez, M.d, M.D
Family Medicine — Payments: $9,534
Family Medicine $9,534